Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-751 and Docetaxel in Advanced or Metastatic NSCLC
NCT00354562Phase 2Terminated
- Sponsor
- Abbott Laboratories
- Start
- Feb 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of abt-751 in non-small cell lung cancer (NSCLC), sponsored by Abbott Laboratories. Started Feb 2007; status: terminated.
02
Drugs
abt-751
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00354562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354562.